NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vertex Energy, Inc. (NASDAQ: VTNR) between April 1, 2022 and August 8, 2022, both dates inclusive (the “Class Period”), of the important June 12, 2023 lead plaintiff deadline. SO WHAT: If you purchased Vertex Energy securities […]
ROSEN, A LEADING LAW FIRM, Encourages Tupperware Brands Corporation Investors to Secure Counsel Before Important May 19 Deadline in Securities Class Action First Filed by the Firm – TUP
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tupperware Brands Corporation (NYSE: TUP) between March 10, 2021 and March 16, 2023, both dates inclusive (the “Class Period”), of the important May 19, 2023 lead plaintiff deadline in the securities class action commenced by the […]
TSE INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Trinseo PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – TSE
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities Trinseo PLC (NYSE: TSE) between May 3, 2021 and March 27, 2023, both dates inclusive (the “Class Period”), of the important June 20, 2023 lead plaintiff deadline in the securities class action commenced by the Firm. SO […]
EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Icahn Enterprises L.P. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IEP
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Icahn Enterprises L.P. (NASDAQ: IEP) between August 2, 2018 and May 9, 2023, both dates inclusive (the “Class Period”). A class action […]
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling and Target Identification, available for free. Through seven lectures, the course guides participants through the latest insights in disease modeling and target discovery – critical areas in […]